for the Period Ended 31 October 2023
| Company Information - 3 | |
| Report of the Directors - 4 | |
| Profit and Loss Account - 5 | |
| Balance sheet - 6 | |
| Footnotes to the Balance Sheet - 8 |
for the Period Ended 31 October 2023
| Director: |
|
|
| Registered office: |
England |
|
| Company Registration Number: |
|
|
The directors present their report with the financial statements of the company for the period ended 31 October 2023
Principal Activities
Additional information
Aircraft lease income is expected to remain low until 2026 when the Medical Transplant System is due to go online.
Directors
The directors shown below have held office during the whole of the period from 01 November 2022 to 31 October 2023
This report was approved by the board of directors on
And Signed On Behalf Of The Board By:
Name:
Status: Director
for the Period Ended 31 October 2023
2023 £ |
2022 £ |
|
|---|---|---|
| Turnover |
|
|
| Income from coronavirus (COVID-19) business support grants | 0 | 0 |
| Other Income |
|
|
| Cost of Materials |
(
|
(
|
| Staff Costs |
(
|
(
|
| Depreciation and Writeoffs |
(
|
(
|
| Other charges |
(
|
(
|
| Tax on Profit |
(
|
(
|
| Profit or (Loss) for Period |
|
|
As at
2023 £ |
2022 £ |
|
|---|---|---|
| Called up share capital not paid: |
|
|
| Fixed Assets: |
|
|
| Current assets: |
|
|
| Prepayments and accrued income: |
|
|
| Creditors: amounts falling due within one year: |
( |
( |
| Net current assets (liabilities): |
( |
|
| Total assets less current liabilities: |
|
|
| Creditors: amounts falling due after more than one year: |
( |
( |
| Provision for liabilities: |
( |
( |
| Accruals and deferred income: |
( |
( |
| Total net assets (liabilities): |
( |
( |
| Capital and reserves: |
( |
( |
This report was approved by the board of directors on
And Signed On Behalf Of The Board By:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 October 2023
for the Period Ended 31 October 2023